FDA Pulls Emergency Use Authorization for Drugs Used in Florida's COVID Clinics Because No One Can Tell Them No

One of the hallmarks of Florida's response to the COVID "Pandemic" has been that it not only encourages residents to get vaccinated, but it provides no-cost therapeutics via a network of clinics.

Back in September, the Biden administration preemptively took control of the distribution of the monoclonal antibodies used by Florida's program and began throttling the number of doses available for distribution in Florida's clinical network.

As if to underscore this hostility, late Monday, the Food and Drug Administration preemptively pulled the Emergency Use Authorization for the primary monoclonal antibodies used by Florida.

First, the FDA has furnished no clinical data to substantiate its claim that the drugs used by Florida clinics are not effective against the "Omicron" variant of the virus.

What is worse, according to the communications director of the Florida Department of Health, the drug the FDA is foisting off on Florida iswellsuboptimal.

"Rather than giving Americans the option for various COVID treatments, the FDA and the Biden Administration issued their royal decree, taking away the very thing that is proven to reduce hospitalizations and save lives," said Lieutenant Governor Jeanette Nuñez.

"Monoclonal antibody treatments like Regeneron have had a positive impact for thousands of Floridians. For the CDC and FDA, which have been consistently inconsistent throughout the entire pandemic, to restrict treatment does nothing but put individuals at risk."

https://redstate.com/streiff/2022/01/25/fda-pulls-emergency-use-authorization-for-drugs-used-in-floridas-covid-clinics-because-no-one-can-tell-them-no-n512257